Introduction
The E1A region of human adenoviruses codes for two major protein isoforms of 289 (289R) and 243 (243R) amino acids. Between these two proteins, the 243R protein (coded by the 12S mRNA) alone can be sufficient to induce proliferation of quiescent cells and to mediate oncogenic transformation in cooperation with other cellular and viral oncogenes (reviewed by Berk, 2005) . Due to the important biological activities (that is, cell proliferation and oncogene cooperation) controlled by the 243R protein, it is widely studied as a model oncoprotein to dissect critical regulatory steps in proliferation of animal cells. The N-terminal half (exon 1) of the 243R protein plays a major role in modulating cell proliferation and in oncogene cooperation. The functions of exon 1 are critically dependent on the interaction of the 243R protein with three different protein complexes formed by cell-cycle regulatory proteins: the pRb family members (pRb, p107 and p130), the histone acetyl transferases (HATs) p300/CBP and the TRRAP/p400 complex.
In contrast to the exon 1 region of E1A, the exon 2 region is dispensable for some activities of E1A, notably cooperative transformation of primary rodent epithelial cells with the activated Ras oncogene. Significantly, 243R mutants lacking the C-terminal 76 amino-acid region confer a hyper-transforming phenotype in Ras cooperative transformation assays (Subramanian et al., 1989) . Within the C-terminal region, sequences encompassing a conserved (among the E1A proteins of all primate Ads) Pro-Leu-Asp-Leu-Ser (PLDLS) motif interact with two related cellular proteins (CtBP1 and CtBP2) collectively known as C-terminal binding proteins (CtBP) (Boyd et al., 1993; Schaeper et al., 1995) . Although CtBPs possess diverse cytosolic and nuclear functions, they primarily function as transcriptional corepressors by recruiting several histone-modifying enzymes (reviewed in Chinnadurai, 2007a, b) . The mechanism by which the C-terminal region of E1A modulates the transforming activities of E1A is not fully understood. It was reported that the CtBP-binding region of E1A antagonized a transcriptional activation function encoded by the N-terminal region (NTR) of E1A in cis in a tethering transcriptional assay (Sollerbrant et al., 1996) . Using a similar transcriptional reporter assay, we have shown that between the two human CtBPs, CtBP2 repressed E1A transcriptional activity whereas CtBP1 did not (Zhao et al., 2006a) . This CtBP2-mediated repression requires not only the PLDLS-dependent interaction with the E1A C-terminal domain, but also the NTR of CtBP2.
The mammalian CtBP2 gene is functionally redundant with the CtBP1 gene for certain developmental functions, in addition to their unique functions (Hildebrand and Soriano, 2002) . The mammalian CtBP2 locus codes for three protein isoforms, CtBP2-L, CtBP2-S and Ribeye (reviewed in Chinnadurai, 2007a) . CtBP2-L and CtBP2-S isoforms vary in the absence of a 20 amino-acid domain in CtBP2-S at the N-terminus (Verger et al., 2006) . The Ribeye protein that plays a role in synapses also lacks the unique N-terminal domain of CtBP2-L, but contains a different large N-terminal domain (Schmitz et al., 2000) . The NTR of CtBP2-L (referred here as CtBP2) is modified by acetylation (Zhao et al., 2006b) and plays a critical role in nuclear localization of CtBP2 (Bergman et al., 2006; Verger et al., 2006; Zhao et al., 2006b) . Here, we report that the CtBP2 NTR alone is sufficient to antagonize the transcriptional activation and cell proliferation functions of the exon 1 region of E1A. As the CtBP2 NTR is located outside the CtBP sequences known to be involved in recruitment of histone-modifying enzymatic constituents of the CtBP corepressor complex, such as histone deacetylases (HDACs), methylases and a lysine-specific demethylase (Kuppuswamy et al., 2008) , it appears that the CtBP2 NTR may inhibit the transcriptional and cell proliferation activities of E1A by a novel mechanism.
Results
Inhibition of E1A-mediated transcriptional activation by the unique CtBP2 NTR We previously reported that CtBP2 efficiently repressed the transactivation activity of the E1A CR1 region in a Gal4 tethering transcriptional assay (Zhao et al., 2006a) Such inhibitory effect was not observed with CtBP1. As the E1A functions normally depend on interaction with HATs through CR1 and interaction with the Rb family members through CR2, we examined if the transcriptional inhibitory activity of CtBP2 also functions on full-length E1A. A luciferase reporter assay was performed by transfection of the CtBP1/2-knockout cell line MEF90 with the pG5-MLP-Luc reporter plasmid, pGal4-E1A, and CtBP2 ( Figure 1a ). As shown, Gal4-E1A activated the G5-MLP promoter by B10-fold, whereas inclusion of CtBP2 reduced the luciferase activity by approximately 50%. A CtBP2 mutant (M48A) capable of binding to E1A, but not with cellular PLDLS-motif proteins, was previously shown to inhibit the transactivation function of E1A CR1 (Zhao et al., 2007) . This mutant also repressed Gal4-E1A (Figure 1a , no. 4). In contrast, mutant L35A, which does not interact with E1A, was defective in repression of Gal4-E1A (Figure 1a , no. 5). Thus, CtBP2 repression of the E1A transactivation function is correlated with CtBP2 interaction with E1A. Consistent with the previous report, only the wild-type (wt) CtBP2 repressed the cellular E-cadherin promoter activity whereas both M48A and L35A mutants failed to repress the E-cadherin promoter (Figure 1b) . The failure of both M48A and L35A mutants to repress the E-cadherin promoter was correlated with defective binding of both mutants to cellular repressors such as ZEB1, one of the repressors of the E-cadherin promoter (Zhao et al., 2007) .
The transcriptional activity of E1A depends on recruitment of HAT and is subject to negative regulation by HDACs. As CtBP is known to recruit HDACs, we examined if CtBP2 repression of the E1A transactivation function is mediated by HDACs. During reporter assays, the transfected MEF90 cells were treated with the HDAC inhibitor trichostatin A (TSA; 0.2 ng/ml for the duration of transfection) and luciferase assays were performed. While TSA treatment did not affect the ability of CtBP2 and M48A-CtBP2 to inhibit the E1A transactivation function (Figure 1a ), TSA abolished CtBP2-mediated repression of the E-cad promoter ( Figure 1b) . Thus, CtBP2 repression of the E-cad promoter appears to be mostly mediated by HDACs whereas the repression of the E1A transactivation function appears to be independent of HDACs.
We previously reported that CtBP2 repression of the transactivation function of E1A CR1 was abolished when the CtBP2 NTR was deleted (Zhao et al., 2006a) . In the luciferase reporter assay employing full-length Gal4-E1A (Figure 1c ), 3KR-CtBP2 (deficient in acetylation by p300) repressed Gal4-E1A to a similar extent as the wt CtBP2, whereas deletion of the entire NTR abolished the inhibitory activity (Figure 1c , no. 5). As expected, CtBP1 did not have significant inhibitory activity (Figure 1c, no.6 ). Strikingly, the construct N2-CtBP1, which contains the N-terminal 20 residues of CtBP2 induced strong repression (Figure 1c , no. 7). These results suggest that the N-terminal 20 amino-acid region of CtBP2 is essential for repression of the E1A transactivation function.
Inhibition of E1A transactivation function by the CtBP2 NTR in cis The precise mechanism of transcriptional activation by the E1A NTR that encompasses the CR1 region is not known. However, it is possible that this activity might be mediated by HAT enzymes that associate with the E1A NTR. We have previously shown that E1A facilitates the formation of a p300-E1A-CtBP2 ternary complex and enhances acetylation of CtBP2 NTR by p300 (Zhao et al., 2006a) . The observation that the CtBP2 NTR is also the critical determinant for inhibition of E1A transactivation (Figure 1 ) suggests the possibility that once recruited into the E1A complex, the CtBP2 NTR may be sufficient for transcriptional repression. To examine whether the CtBP2 NTR could autonomously inhibit the transcriptional activation function of E1A, we examined the activity of a Gal4 E1A-CtBP2 construct expressing a fusion protein consisting of N-terminal 177 residues of E1A 243R, the CtBP2 NTR and the E1A NLS along with the Gal4-DBD (Figure 2a ). The transcriptional activities of various Gal4-E1A fusion constructs shown in Figure 2a were examined by co-transfection with the pG5-MLP-Luc reporter in the human breast cancer cell line MCF7 (Figure 2b ). These reporter assays showed that while Gal4-E1A did not significantly activate the promoter, the Gal4-E1A-C* mutant, which carries a PLDLS-PLASS mutation and does not interact with CtBP (Zhao et al., 2006a) , strongly activated the promoter. The activity of Gal4-177C with a large C-terminal deletion was further increased. Strikingly, Gal4-177N2C, which contains the CtBP2 NTR, had essentially no transactivation activity. Immunofluorescence analysis of Gal4-E1A fusion proteins suggested that Gal4-177N2C was localized in the nucleus as efficiently as Gal4-177C (Figure 2c ). These results suggest that the CtBP2 NTR strongly inhibits the E1A transactivation function, autonomous of other CtBP2 sequences.
To examine whether the presence of the CtBP2 NTR affected the interaction of E1A with cellular proteins, Flag-HA (FH)-tagged E1A177C and E1A177N2C were expressed in HeLa cells using retroviral transduction. FHtagged E1A complexes were immunoprecipitated with the Flag antibody and examined by western blots with various antibodies. As shown in Figure 2d , FH-177C and FH-177N2C both interacted well with TRRAP, p400 and pRb. The interaction of these E1A proteins with p300 was not detectable by this approach. However, when these expression constructs were transiently transfected into 293 cells (Figure 2e ), both FH-177C and FH-177N2C interacted with p300. The efficiency of FH-177C and FH-177N2C interaction with p300 was lower than those for other E1A cofactors, possibly due to the presence of the FH-tag at the N-terminus.
To examine the specificity of CtBP2 NTR in repression of E1A transcriptional activity, we generated several point mutants of the CtBP2 NTR in the context of Gal4-177N2C (Figure 3a) . These include mutant 3KR, which carries Lys-Arg substitutions for Lys6, Lys8 and Lys10 of CtBP2 NTR (Zhao et al., 2006b) , mutant 3KA, which carries Lys-Ala substitutions for the same residues of CtBP2 NTR, and mutant N1-2C, which contains a substitution of the N-terminal 12 residues of CtBP1 for the N-terminal 12 residues of CtBP2 NTR. The luciferase reporter assays (Figure 3b ) indicated significant relief of transcriptional inhibition by the 3KA mutation, whereas the 3KR mutation had only a small effect. Importantly, the mutant Gal4-177N1-2C carrying a chimeric CtBP1-CtBP2 NTR had a much higher transcriptional activity than Gal4-177N2C. Thus, the transcriptional repression activity of the CtBP2 NTR appears to be specific and this activity critically depends on the N-terminal 12 residues of CtBP2.
Repression by CtBP2 NTR independent of E1A CR2 The E1A177C construct was previously shown to be hyper transforming in E1A/ras co-transformation assay (Subramanian et al., 1989) . The transcriptional activity of the Gal4-E1A177C construct may be influenced by two types of interactions: N-terminal-mediated interaction with HATs either directly (for example, p300/CBP, P/CAF) or indirectly through scaffolding adapter molecules such as TRRAP (for example, GCN5) (Wang Eckner et al., 1994; Reid et al., 1998; Fuchs et al., 2001; Lang and Hearing, 2003) , and CR2-mediated interaction with pRb members (Whyte et al., 1989) . To determine the roles of the different E1A domains in CtBP2 NTR-mediated repression in cis, three different E1A deletion mutants (D2-11, D26-35 and DCR2) were introduced into pGal4-E1A177C (Figure 4a ). These mutations have previously been shown to individually abolish interactions with major protein complexes, p300/CBP (mutant D2-11), TRRAP/ p400 (mutant D26-35) and pRb family proteins (mutant DCR2; Samuelson et al., 2005) . Additionally, a deletion mutant D2-74 that would be expected to be deficient in interaction with all HATs was also constructed. The transcriptional activities of the various mutants were assayed by using the reporter pG5-MLP-Luc in MCF7 cells (Figure 4b) . Deletion of the CR2 region in Gal4-E1A177 (DCR2) resulted in significant increase in the transcriptional activity (Figure 4b , no. 6), suggesting that association of pRb family proteins may be inhibitory to the transcriptional activity of the chimeric construct. Deletion of domains involved in interaction with p300 (D2-11) (Figure 4b, no. 3) or TRRAP/p400 complex (D26-35; Figure 4b , no. 4) did not impair the transcriptional activity whereas deletion of the region encompassing both domains (D2-74; Figure 4b , no. 5) abolished the activity, suggesting that the two Nterminal protein interaction domains function redundantly to activate transcription when targeted to the promoter. These results suggest that the transcriptional activation function of the E1A exon 1 region is primarily contributed by the N-terminal HAT-recruiting domains.
As the CtBP2 NTR efficiently inhibited this activity (Figure 2) , our results suggest that CtBP2 antagonizes the activities of the transcriptional effector molecules recruited by the E1A NTR.
As the presence of CR2 repressed the transcriptional activity of E1A, there was a possibility that CtBP2 NTR could suppress E1A activity by enhancing a potential repressive activity of CR2. To examine this possibility, CtBP2 NTR was incorporated into pGal4-177C(DCR2) to generate pGal4-177N2C(DCR2) (Figure 4a) . As a control, pGal4-177N1-2C(DCR2), which carries a chimeric CtBP1 CtBP2 N-terminal sequence (Figure 4a ), was also prepared. As shown in Figure 4b , insertion of the CtBP2 NTR (as in the construct pGal4-177N2C(DCR2)) strongly inhibited the transactivation function of Gal4-177C(DCR2) (compare nos. 6 and 7 in Figure 4b ). Insertion of the CtBP1-CtBP2 chimeric NTR (as in the construct pGal4-177N1-2C(DCR2)) had only a small effect on the transactivation function of Gal4-177C(DCR2) (Figure 4b , no. 8). Thus, CtBP2 NTR does not appear to suppress E1A transcriptional activity by targeting CR2. The function of the CtBP2 NTR appears to be the same whether CR2 is absent (Figure 4b , no. 7 and no. 8) or present (Figure 4b, no. 10 and no. 11 ). This result is consistent with the previous result that the full-length CtBP2 represses the transcriptional activity of E1A CR1. Thus, the repression activity of the CtBP2 NTR in cis with E1A177C appears to represent an authentic activity of the full-length CtBP2. Western blot analysis with an antibody against E1A residues no. 1-80 showed that all Gal4-E1A proteins were expressed similarly (Figure 4b, lower panel) . Gal4-177C(D2-74) (Figure 4b , no. 5) could not be detected by this antibody. However, its expression level was the highest because this mutant was the only protein detectible by the Gal4 antibody (not shown).
Effect of HDAC inhibitor on CtBP2 NTR-mediated repression of E1A transcriptional activity To understand the potential roles of HDAC in CtBP2 NTR-mediated repression, luciferase reporter assays were performed in MCF7 cells transfected with the G5-MLP-Luc reporter and Gal4-177C or Gal4-177N2C constructs in the presence or absence of TSA ( Figure 5 ). As expected, in the absence of TSA, Gal4-177N2C had a much lower transcriptional activity than Gal4-177C. In the presence of TSA, the transcriptional activities of both Gal4-177C and Gal4-177N2C were enhanced; however, the relative levels of their activities remained little changed. Thus, while TSA enhanced the transcriptional activity mediated by the E1A NTR, TSA did not rescue the transcriptional repression mediated by the CtBP2 NTR.
As the Gal4-177C(DCR2) construct had a much higher activity than Gal4-177C (Figure 4) , we also compared Gal4-177C(DCR2) and Gal4-177N2C(DCR2) for their transcriptional activities in the presence or absence of TSA. As shown in Figure 5 , TSA greatly enhanced the transcriptional activity of Gal4-177C(DCR2), whereas the activity of Gal4-177N2C(DCR2) was enhanced by TSA to a much lower level. Thus, HDAC and CtBP2 NTR-mediated repressions of E1A transcriptional activity are most likely through separate mechanisms.
Inhibition of E1A-induced cellular proliferation by the CtBP2 NTR Primary baby rat kidney (BRK) cells are widely used to study cell proliferation (Zerler et al., 1987) and transforming (Graham and van der Eb, 1973 ) activities of E1A. BRK cells transduced with E1A 12S expression vectors or infected with Ad 12S virus undergo transient proliferation resulting in visible colonies of proliferating cells. In the absence of other oncogenic stimuli, these cells undergo terminal growth arrest and die. We have used the BRK model to determine the effect of the CtBP2 NTR on E1A-induced cell proliferation. Primary BRK cells were transduced with pBABE retrovirus vector or pBABE vectors expressing different E1A constructs, and 5 days later stained with Giemsa. In cells transduced with the vector, there were no detectable proliferating cell colonies (Figure 6a, left) . However, in cells transduced with the retrovirus expressing E1A, numerous colonies of proliferating BRK epithelial cells were readily visible (Figure 6a, right) . To determine the effect of the CtBP2 NTR, the relative number of proliferating colonies induced by wt E1A (243R) and E1A177C were compared with those induced by E1A177N2C or E1A177N1-2C (Figure 6b ). Although wt E1A and E1A177C efficiently induced proliferating cell colonies, E1A177N2C induced much less number of colonies. (We note that E1A-177C when expressed from the adenoviral genome induces more efficient proliferation than E1A 12S in short-term proliferation assays, not shown.) The number of colonies induced by E1A177N1-2C (which contains substitution of the N-terminal 12 residues of the CtBP2 NTR with the N-terminal 12 residues of CtBP1), was more than that induced by E1A177N2C. However, E1A177N1-2C was still weaker than E1A177C in inducing cell proliferation, suggesting that the CtBP1 sequence in E1A177N1-2C partially relieved the cellproliferation inhibitory activity of the CtBP2 NTR.
Discussion
Despite the overall high degree of sequence similarity between CtBP1 and CtBP2, and their ability to strongly interact with E1A, our previous results suggested that only CtBP2 inhibited a transcriptional activation function encoded by the E1A NTR encompassing the CR1 region of E1A exon 1. Here, we have shown that this specificity of CtBP2 extends to transcriptional activation mediated by the full-length 243R protein. Importantly, we demonstrate that the CtBP2 NTR alone can repress the transactivation function of E1A, when fused to the C-terminal region of E1A. It appears that the repression activity of the CtBP2 NTR might be independent of the common transcriptional repression factors associated with CtBP1 and CtBP2. As expected from the shared homology between CtBP1 and CtBP2, in co-immunoprecipitation analyses, CtBP2 (Zhao et al., 2006a) was found to interact with most of the cofactors associated with CtBP1 (Kuppuswamy et al., 2008; Shi et al., 2003) , including factors, such as HDAC1/2, G9a, LSD1/ CoREST that play critical roles in transcriptional repression. Consistent with the similarity in the patterns of cofactor recruitment, both CtBP1 and CtBP2 repressed the E-cadherin promoter at comparable levels (Zhao et al., 2006a) . Surprisingly, when analysed for repression of the transcriptional activity of Gal4-E1A, CtBP2 was found to be more efficient than CtBP1 (Zhao et al., 2006a; Figure 1c) .
Our present study indicates that the functional difference between CtBP1 and CtBP2 with regard to inhibition of E1A exon 1 function is primarily determined by the unique CtBP2 NTR. Substitution of the N-terminal 20 residues of CtBP2 for the N-terminal 14 residues of CtBP1 conferred E1A-repressive activity to CtBP1 (Figure 1c) . One interpretation of this result is that the CtBP2 NTR may influence CtBP2 interaction with transcription repressors or other cofactors. However, comparable levels of repression of the E-cadherin by both CtBP1 and CtBP2 were observed (Zhao et al., 2006a) , suggesting that the differential activity may be unrelated to recruitment of the common repressive cofactors, such as HDACs. This conclusion is strengthened by the results that the E1A-repressive activity of CtBP2 NTR was unaffected by the HDAC inhibitor TSA ( Figure 5) . Thus, the CtBP2 NTR may inhibit transcriptional activation by a unique mechanism.
Our results suggest that the CtBP2 NTR might possess an autonomous transcriptional repression activity in the context of E1A. The function of CtBP2 NTR is specific because substitution of the first 12 residues of CtBP1 for the first 12 residues of CtBP2 strongly relieved the repressive activity on Gal4-177N2C (Figure 3 ), whereas substitution of Arg residues for Lys residues in NTR had only a small relieving effect. Substitution of Ala residues for Lys residues had an intermediate level of relief of repression, suggesting that the presence of basic residues at Lys6, Lys8 and Lys10 is important for the repression activity of the CtBP2 NTR. The function of CtBP2 NTR does not appear to be mediated through the Rb pathway because removal of CR2 from E1A did not affect the ability of CtBP2 NTR to inhibit E1A transactivation ( Figure 4) . As demonstrated here, the transcriptional activation function of E1A requires the NTR of E1A that recruit different HATs. It is tempting to speculate that the CtBP2 NTR may target the HATs. We and others have shown that the CtBP2 NTR serves as nuclear localization/retention signal for CtBP2 (Bergman et al., 2006; Verger et al., 2006; Zhao et al., 2006b ). This activity is linked to acetylation of three lysine residues of the CtBP2 NTR (Zhao et al., 2006b) . As substitution of the Lys residues with Arg residues abolishes nuclear localization of CtBP2, but retains substantial repressive activity on Gal4-E1A (Figure 3 ), it appears that the transcriptional repression activity of the CtBP2 NTR may not require acetylation. The possibility that the NTR may mediate its transcriptional repression activity by recruiting novel transcription factors remains an attractive future avenue of investigation.
Incorporation of CtBP2 NTR into E1A resulted in strong inhibition of E1A transcriptional activity as well as E1A's ability to induce cellular proliferation (Figure 6) . Although it appears that these two activities may be related, our present results do not permit establishing a clear correlation between these two activities. This is partly due to the lack of a suitable assay for the transactivation activity of the native 243R protein. Nonetheless, our study has discovered an independent (of other CtBP sequences) function for the CtBP2 NTR that can antagonize E1A activities in cis. Thus, the interaction of E1A with CtBP may regulate cell proliferation by relieving the effects of CtBPs on transcription of cellular genes as well as by CtBP2-specific modulation of E1A activities.
Materials and methods

Plasmid constructs
Gal4-E1A fusion constructs, expressing the Gal4 DNAbinding domain and E1A were constructed in the backbone of pIRESneo vector (Clontech, Mountain View, CA, USA). pGal4-E1A177C was constructed by transferring the E1A BamHI/EcoRI fragment of pGFP-E1A(177-9) (Subramanian et al., 1989) to the pGal4 vector. Fusion constructs between E1A177C and CtBP2 NTR were prepared by substituting the XbaI/EcoRI fragment of pGal4-E1A177C with a synthetic fragment. CtBP expression constructs have been described earlier (Zhao et al., 2006a, b) .
Retroviral constructs
Ad2 E1A 12S cDNA was PCR amplified using primers, no. N21 GACCACGGATCCATGAGACATATTATCTGCCAC GG and no. N20 TTCGACGAATTCTTATGGCCTGGGG CGTTTACAGCTC, and cloned at the BamHI/EcoRI sites of the pBABE-puro vector to generate pBABE-E1A. In this construct, E1A expression is driven by the retroviral LTR. pBABE-E1A177C, E1A177N2C and E1A177N1-2C were generated by transferring the BamHI-EcoRI fragment from the Gal4 fusion constructs to the pBABE-puro vector. To express Flag-HA-(FH) tagged versions of E1A177C and E1A177N2C, XhoI/EcoRI fragments of pGal4-E1A177C and pGal4-E1A177N2C were transferred to the pBABE-CMV vector expressing the FH tag under the control of the cytomegalovirus (CMV) promoter.
Cell culture, transfection, luciferase reporter assays, immunofluorescence analysis, co-immunoprecipitation and western blots Conditions for these analyses were as described in previous reports (Zhao et al., 2006a, b) .
Retroviral infection
Retroviruses were generated by transfection of the Phoenixamphotropic packaging cell line (Grignani et al., 1998) by the calcium phosphate method. Cells in six-well plates were infected with aliquots of retroviruses in the presence of 8 mg/ ml polybrene. Infected cells were subjected to selection with Puromycin (0.5 mg/ml) from 24 h after infection and cells were stained with Geimsa 5 days after infection and photographed.
